Recurrent Primitive Neuroectodermal Tumor
4 clinical trials · Condition
◉ Watch Recurrent Primitive Neuroectodermal Tumor
| Record | Firm | Date |
|---|---|---|
| Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer (NCT04521946) | M.D. Anderson Cancer Center | 2021-01-14 |
| Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors (NCT02444546) | Mayo Clinic | 2015-06-21 |
| Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors (NCT01217437) | National Cancer Institute (NCI) | 2010-11-22 |
| Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors (NCT00983398) | OHSU Knight Cancer Institute | 2009-07-09 |
Track Recurrent Primitive Neuroectodermal Tumor automatically
Every clearance here is in the API, with alerts when new ones post.